700 patients110,866 observations180 daysLIVE

Patient P-02591

Synthetic patientMETA-24 · Day 169 · 75+ · M · baseline S13Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Improving
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Unstable
Discontinuation risk
55%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S13
  2. Day 10 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 10.

Primary contributors, last 14 days
  • Toxicity-15
  • GI instability-13
  • Inflammatory activity-13
  • Nutritional resilience+9
  • Treatment adherence-4

What helped?

No interventions yet.

    LIFE OS recommendation
    GI Support Protocol GI-04
    61%
    probability of meaningful tolerance improvement
    • 284 similar trajectories
    • 89% showed improvement
    • median effect visible after 8 days

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    48 min
    stable · +0.3 vs previous 14 d
    Sleep duration
    Wearable
    6.1 h
    stable · +0.2 vs previous 14 d
    Energy level
    Daily log
    3.6/10
    stable · +0.1 vs previous 14 d
    Steps
    Wearable
    5,142
    stable · +70 vs previous 14 d
    GI burden
    Companion
    53.6/100
    improving · -6.3 vs previous 14 d
    Adherence
    Companion
    64.2 %
    worsening · -6.1 vs previous 14 d
    Sleep quality
    Wearable
    26.5/100
    improving · +5.6 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    140 mg/dL
    stable · -1.2 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 49 from the failing basin, 48 from restoration.

    Good elements to keep
    • Protein (supports)
      perturbation · steering +10.6
    • Protein
      supporter · GI -6.4 next day
    Main detractors to watch
    • Low butyrate capacity
      hidden · steering -17.5
    • Dietary fat load
      perturbation · steering -11.1
    • Alcohol
      perturbation · steering -10.3
    • Low microbial diversity
      hidden · steering -7.7
    • Dietary fat load
      detractor · GI +6.5 next day
    • Alcohol
      detractor · GI +5.4 next day
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Dietary fat load
      +6.5detractor · 95%
    • Protein
      -6.4supporter · 95%
    • Alcohol
      +5.4detractor · 95%
    • Simple carbohydrates
      +4.4detractor · 95%
    • Ultra-processed food
      +4.3detractor · 95%
    • Caffeine
      +1.6no signal · 34%
    • Histamine load
      +0.5no signal · 15%
    • Insoluble fibre
      0no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Mucosal barrier integrity 60
      • MicrobiomeAkkermansia low → thinner mucus layer
      • Daily logGI symptom score 54 and rising
      • WearableSleep 6.1 h, below personal baseline
    • Butyrate / short-chain fatty acid production 55
      • MicrobiomeButyrate capacity 38/100
      • Daily logFibre intake low in recent food logs
    • Autonomic recovery 45
      • WearableResting HR 80 bpm
      • WearableShort sleep window
    • Inflammatory signalling 40
      • BloodInflammatory load index 53
      • WearableHRV 25 ms, trending down
    • Drug metabolism and exposure 20
      • BloodToxicity index 54
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Normal metabolizer
      Expected exposure
    • MTHFR C677T
      Reduced folate turnover
    Microbiome
    Shannon diversity 2.7 · butyrate capacity 38/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisNormal
    • Bifidobacterium longumLow
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    20 ms
    Sleep
    6.2 h
    Steps
    4,930
    Resting HR
    82 bpm
    Daily log: GI score 54, nutritional resilience 39, adherence 64.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
    • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Track each bowel movement today: time, stool form, urgency, overnight waking
    • Keep the current walking rhythm
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • Electrolyte solution, one sachet after any loose stool
    • Fictional demo item: oral nutrition supplement with lunch

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0205443%S01CR-01improved57
    P-0240935%S01SC-12no change54
    P-0201832%S01GI-04improved46
    P-0241031%S01GI-04improved55
    P-0230723%S0155
    P-0255023%S0170
    P-0259823%S0153
    P-0227621%S0157
    P-0243721%S0164
    P-0256821%S0151
    P-0213820%S0179
    P-0221720%S0161